| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 10,190,000 | 10,551,000 | 10,055,000 | 13,280,000 | | Cost of Revenue | 7,419,000 | 7,756,000 | 7,182,000 | 9,627,000 | | | Gross Profit | 2,771,000 | 2,795,000 | 2,873,000 | 3,653,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,664,000 | 2,630,000 | 2,573,000 | 2,820,000 | | Non Recurring | 59,000 | (5,000) | (54,000) | 348,000 | | Others | 224,000 | 228,000 | 226,000 | 160,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (106,000) | (58,000) | 128,000 | 325,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 70,000 | (17,000) | (11,000) | 36,000 | | Earnings Before Interest And Taxes | (106,000) | (75,000) | 117,000 | 361,000 | | Interest Expense | 72,000 | 63,000 | 59,000 | 70,000 | | Income Before Tax | (178,000) | (138,000) | 58,000 | 291,000 | | Income Tax Expense | (66,000) | (52,000) | 24,000 | 130,000 | | Minority Interest | (31,000) |
-
|
-
| 29,000 | | | | Net Income From Continuing Ops | (143,000) | (86,000) | 34,000 | 190,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (143,000) | (86,000) | 34,000 | 190,000 | | Preferred Stock And Other Adjustments | 16,000 | (8,000) | (8,000) |
-
| | | Net Income Applicable To Common Shares | ($127,000) | ($94,000) | $26,000 | $190,000 |
|
0.31% Nasdaq 
0.05%
Income Statement
